Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record is available, describing a completed Phase 2 study of pembrolizumab with radiation for cisplatin-ineligible patients with locally advanced head and neck cancer. It includes participant eligibility and study locations, treatment and outcome details, and a linked study protocol.
    Difference
    51%
    Check dated 2026-11-08T10:19:14.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T11:33:40.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH updates about replacing the term “Artificial Intelligence” with “Super Intelligence” during a transition. The clinical study record itself remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T12:00:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer's site revision indicator changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T12:15:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:30:01.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, indicating the resource is inaccessible and preventing viewing the study details on this page.
    Difference
    19%
    Check dated 2026-09-20T20:00:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.